Bemarituzumab
Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding to FGF and activation. Potential applications of Bemarituzumab in cancer research.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
FGFR
CAS Number
1952272-74-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
P00024-6 100 µL
Anti-Phospho-Akt (Ser473) AKT1 Rabbit Monoclonal Antibody, Clone#RM251
Ask
View Details 